[{"orgOrder":0,"company":"Benha University","sponsor":"New Jeddah Clinic Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"EGYPT","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Midodrine","moa":"Adrenergic receptor alpha-1","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Benha University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Benha University \/ New Jeddah Clinic Hospital","highestDevelopmentStatusID":"1","companyTruncated":"Benha University \/ New Jeddah Clinic Hospital"},{"orgOrder":0,"company":"NYU Langone Health","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Sodium Chloride","moa":"Apolipoprotein C-III mRNA 3'UTR","graph1":"Nephrology","graph2":"Undisclosed","graph3":"NYU Langone Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NYU Langone Health \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"NYU Langone Health \/ Undisclosed"},{"orgOrder":0,"company":"Indiana University","sponsor":"Sanofi | Purdue University","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2010","type":"Inapplicable","leadProduct":"Calcium Carbonate","moa":"Calcium","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Indiana University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indiana University \/ Sanofi | Purdue University","highestDevelopmentStatusID":"1","companyTruncated":"Indiana University \/ Sanofi | Purdue University"},{"orgOrder":0,"company":"University of Washington","sponsor":"American Diabetes Association | Medtronic plc | Abbott Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Linagliptin","moa":"Dipeptidyl peptidase IV","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Washington","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Washington \/ American Diabetes Association | Medtronic plc | Abbott Laboratories","highestDevelopmentStatusID":"1","companyTruncated":"University of Washington \/ American Diabetes Association | Medtronic plc | Abbott Laboratories"},{"orgOrder":0,"company":"Ohio State University","sponsor":"Novartis Pharmaceuticals Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Everolimus","moa":"FK506-binding protein 1A","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Ohio State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ohio State University \/ Novartis Pharmaceuticals Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Ohio State University \/ Novartis Pharmaceuticals Corporation"},{"orgOrder":0,"company":"Hershey Medical Center","sponsor":"Novartis Pharmaceuticals Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Everolimus","moa":"FK506-binding protein 1A","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Hershey Medical Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hershey Medical Center \/ Novartis Pharmaceuticals Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Hershey Medical Center \/ Novartis Pharmaceuticals Corporation"},{"orgOrder":0,"company":"Helady Pinheiro, MD, PhD","sponsor":"Novartis Pharmaceuticals Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Everolimus","moa":"FK506-binding protein 1A","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Helady Pinheiro, MD, PhD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Helady Pinheiro, MD, PhD \/ Novartis Pharmaceuticals Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Helady Pinheiro, MD, PhD \/ Novartis Pharmaceuticals Corporation"},{"orgOrder":0,"company":"Northwestern University","sponsor":"Novartis Pharmaceuticals Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Antibiotic","year":"2012","type":"Inapplicable","leadProduct":"Tacrolimus","moa":"FK506-binding protein 1A","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Northwestern University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Northwestern University \/ Novartis Pharmaceuticals Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Northwestern University \/ Novartis Pharmaceuticals Corporation"},{"orgOrder":0,"company":"University of British Columbia","sponsor":"Astellas Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"CANADA","productType":"Antibiotic","year":"2015","type":"Inapplicable","leadProduct":"Tacrolimus","moa":"FK506-binding protein 1A","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of British Columbia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of British Columbia \/ Astellas Pharma","highestDevelopmentStatusID":"1","companyTruncated":"University of British Columbia \/ Astellas Pharma"},{"orgOrder":0,"company":"Columbia University","sponsor":"Pfizer Inc | Cornell University","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Antibiotic","year":"2012","type":"Inapplicable","leadProduct":"Tacrolimus","moa":"FK506-binding protein 1A","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Columbia University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Columbia University \/ Pfizer Inc | Cornell University","highestDevelopmentStatusID":"1","companyTruncated":"Columbia University \/ Pfizer Inc | Cornell University"},{"orgOrder":0,"company":"Taichung Veterans General Hospital","sponsor":"Grape King Bio Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"TAIWAN","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Taichung Veterans General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Taichung Veterans General Hospital \/ Grape King Bio Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Taichung Veterans General Hospital \/ Grape King Bio Ltd."},{"orgOrder":0,"company":"Probiotical","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"ITALY","productType":"Probiotic","year":"2019","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Probiotical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Probiotical \/ Azienda Ospedaliero Universitaria Maggiore della Carita","highestDevelopmentStatusID":"1","companyTruncated":"Probiotical \/ Azienda Ospedaliero Universitaria Maggiore della Carita"},{"orgOrder":0,"company":"GenMont Biotech Incorporation","sponsor":"Chung Shan Medical University","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Nephrology","graph2":"Undisclosed","graph3":"GenMont Biotech Incorporation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GenMont Biotech Incorporation \/ Chung Shan Medical University","highestDevelopmentStatusID":"1","companyTruncated":"GenMont Biotech Incorporation \/ Chung Shan Medical University"},{"orgOrder":0,"company":"University of Rochester School of Medicine & Dentistry","sponsor":"Evgen Pharma","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Partnership","leadProduct":"Sulforaphane","moa":"Inactive rhomboid protein 2 (RHBDF2)","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Rochester School of Medicine & Dentistry","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Rochester School of Medicine & Dentistry \/ Evgen Pharma","highestDevelopmentStatusID":"1","companyTruncated":"University of Rochester School of Medicine & Dentistry \/ Evgen Pharma"},{"orgOrder":0,"company":"Army Health Branch, British Army","sponsor":"University of East Anglia | Osteolabs, GEOMAR","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"UNITED KINGDOM","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Calcium","moa":"Phosphate","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Army Health Branch, British Army","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Army Health Branch, British Army \/ University of East Anglia | Osteolabs, GEOMAR","highestDevelopmentStatusID":"1","companyTruncated":"Army Health Branch, British Army \/ University of East Anglia | Osteolabs, GEOMAR"},{"orgOrder":0,"company":"Tel Aviv Sourasky Medical Center (Ichilov Hospital)","sponsor":"Wolfson Medical Center | Sanofi","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"ISRAEL","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Sevelamer Hydrochloride","moa":"Phosphate","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Tel Aviv Sourasky Medical Center (Ichilov Hospital)","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tel Aviv Sourasky Medical Center (Ichilov Hospital) \/ Wolfson Medical Center | Sanofi","highestDevelopmentStatusID":"1","companyTruncated":"Tel Aviv Sourasky Medical Center (Ichilov Hospital) \/ Wolfson Medical Center | Sanofi"},{"orgOrder":0,"company":"VA New York Harbor Healthcare System","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2010","type":"Inapplicable","leadProduct":"Sodium Thiosulfate","moa":"Platinum\/protein complex","graph1":"Nephrology","graph2":"Undisclosed","graph3":"VA New York Harbor Healthcare System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Solution","sponsorNew":"VA New York Harbor Healthcare System \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"VA New York Harbor Healthcare System \/ Undisclosed"},{"orgOrder":0,"company":"Karolinska Institutet","sponsor":"AstraZeneca","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"SWEDEN","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Sodium Zirconium Cyclosilicate","moa":"Potassium","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Karolinska Institutet","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Serum","sponsorNew":"Karolinska Institutet \/ AstraZeneca","highestDevelopmentStatusID":"1","companyTruncated":"Karolinska Institutet \/ AstraZeneca"},{"orgOrder":0,"company":"Seoul National University Hospital","sponsor":"Astellas Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Beraprost Sodium","moa":"PTGIR","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Seoul National University Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Seoul National University Hospital \/ Astellas Pharma","highestDevelopmentStatusID":"1","companyTruncated":"Seoul National University Hospital \/ Astellas Pharma"},{"orgOrder":0,"company":"University of New Mexico","sponsor":"Dialysis Clinic","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Bumetanide","moa":"Sodium-(potassium)-chloride cotransporter 2","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of New Mexico","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of New Mexico \/ Dialysis Clinic","highestDevelopmentStatusID":"1","companyTruncated":"University of New Mexico \/ Dialysis Clinic"},{"orgOrder":0,"company":"VA New York Harbor Healthcare System","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2016","type":"Inapplicable","leadProduct":"Chlorthalidone","moa":"Thiazide-sensitive sodium-chloride cotransporter","graph1":"Nephrology","graph2":"Undisclosed","graph3":"VA New York Harbor Healthcare System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VA New York Harbor Healthcare System \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"VA New York Harbor Healthcare System \/ Undisclosed"},{"orgOrder":0,"company":"Nova Scotia Health Authority","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"CANADA","productType":"Enzyme","year":"2015","type":"Inapplicable","leadProduct":"Alteplase","moa":"Tissue-type plasminogen activator","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Nova Scotia Health Authority","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nova Scotia Health Authority \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Nova Scotia Health Authority \/ Undisclosed"},{"orgOrder":0,"company":"University of Maryland","sponsor":"Bristol Myers Squibb","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Protein","year":"2011","type":"Inapplicable","leadProduct":"Belatacept","moa":"T-lymphocyte activation antigen CD86 | T-lymphocyte activation antigen CD80","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Maryland","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"University of Maryland \/ Bristol Myers Squibb","highestDevelopmentStatusID":"1","companyTruncated":"University of Maryland \/ Bristol Myers Squibb"},{"orgOrder":0,"company":"Second Xiangya Hospital, Central South University","sponsor":"Baxter Healthcare Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"CHINA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Losartan Potassium","moa":"Type-1 angiotensin II receptor","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Second Xiangya Hospital, Central South University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Second Xiangya Hospital, Central South University \/ Baxter Healthcare Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Second Xiangya Hospital, Central South University \/ Baxter Healthcare Corporation"},{"orgOrder":0,"company":"University of Kragujevac","sponsor":"Pharmanova","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"SERBIA","productType":"Dietary Supplement","year":"2019","type":"Inapplicable","leadProduct":"Alixir 400 Protect","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Kragujevac","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Kragujevac \/ Pharmanova","highestDevelopmentStatusID":"1","companyTruncated":"University of Kragujevac \/ Pharmanova"},{"orgOrder":0,"company":"Massachusetts General Hospital","sponsor":"Elysium Health","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Dietary Supplement","year":"2017","type":"Inapplicable","leadProduct":"Basis","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Massachusetts General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Massachusetts General Hospital \/ Elysium Health","highestDevelopmentStatusID":"1","companyTruncated":"Massachusetts General Hospital \/ Elysium Health"},{"orgOrder":0,"company":"Buddhist Tzu Chi General Hospital","sponsor":"Multipower Enterprise Corp.","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"TAIWAN","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Boscogen","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Buddhist Tzu Chi General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Buddhist Tzu Chi General Hospital \/ Multipower Enterprise Corp.","highestDevelopmentStatusID":"1","companyTruncated":"Buddhist Tzu Chi General Hospital \/ Multipower Enterprise Corp."},{"orgOrder":0,"company":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","sponsor":"Morris Enterprise Co.,Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"TAIWAN","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Eefooton","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation \/ Morris Enterprise Co.,Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation \/ Morris Enterprise Co.,Ltd."},{"orgOrder":0,"company":"Newtricious R&D BV","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"NETHERLANDS","productType":"Protein","year":"2014","type":"Inapplicable","leadProduct":"Egg-White Protein Hydrolysate","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Newtricious R&D BV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Newtricious R&D BV \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Newtricious R&D BV \/ Undisclosed"},{"orgOrder":0,"company":"Leiden University Medical Center","sponsor":"Dutch Kidney Foundation | Health Holland | Radboud University Medical Center","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"NETHERLANDS","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Endocalyx","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Leiden University Medical Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Leiden University Medical Center \/ Dutch Kidney Foundation | Health Holland | Radboud University Medical Center","highestDevelopmentStatusID":"1","companyTruncated":"Leiden University Medical Center \/ Dutch Kidney Foundation | Health Holland | Radboud University Medical Center"},{"orgOrder":0,"company":"Talaris Therapeutics","sponsor":"Northwestern University","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Cell & Gene Therapy","year":"2014","type":"Inapplicable","leadProduct":"Enriched Hematopoetic Stem Cell","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Talaris Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Talaris Therapeutics \/ Northwestern University","highestDevelopmentStatusID":"1","companyTruncated":"Talaris Therapeutics \/ Northwestern University"},{"orgOrder":0,"company":"University of Missouri-Columbia","sponsor":"Dialysis Clinic","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"Propolis","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Missouri-Columbia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Dressing","sponsorNew":"University of Missouri-Columbia \/ Dialysis Clinic","highestDevelopmentStatusID":"1","companyTruncated":"University of Missouri-Columbia \/ Dialysis Clinic"},{"orgOrder":0,"company":"Dong-A University","sponsor":"Baxter Healthcare Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"SOUTH KOREA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Icodextrin","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Dong-A University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dong-A University \/ Baxter Healthcare Corporation","highestDevelopmentStatusID":"1","companyTruncated":"Dong-A University \/ Baxter Healthcare Corporation"},{"orgOrder":0,"company":"Sun Yat-sen University","sponsor":"Fresenius SE & Co. KGaA","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"CHINA","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"Keto Acid","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Sun Yat-sen University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sun Yat-sen University \/ Fresenius SE & Co. KGaA","highestDevelopmentStatusID":"1","companyTruncated":"Sun Yat-sen University \/ Fresenius SE & Co. KGaA"},{"orgOrder":0,"company":"Coordinaci\u00f3n de Investigaci\u00f3n en Salud","sponsor":"Fresenius Kabi AB Brunna","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Ketoanalogues Of Essential Amino Acids","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Coordinaci\u00f3n de Investigaci\u00f3n en Salud","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Coordinaci\u00f3n de Investigaci\u00f3n en Salud \/ Fresenius Kabi AB Brunna","highestDevelopmentStatusID":"1","companyTruncated":"Coordinaci\u00f3n de Investigaci\u00f3n en Salud \/ Fresenius Kabi AB Brunna"},{"orgOrder":0,"company":"Taichung Veterans General Hospital","sponsor":"All Clean Health Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"TAIWAN","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Low Protein Diet","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Taichung Veterans General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Taichung Veterans General Hospital \/ All Clean Health Co., Ltd","highestDevelopmentStatusID":"1","companyTruncated":"Taichung Veterans General Hospital \/ All Clean Health Co., Ltd"},{"orgOrder":0,"company":"Taichung Veterans General Hospital","sponsor":"Fresenius Kabi AG","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"TAIWAN","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Low Protein Diet With Fresubin Renal","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Taichung Veterans General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Taichung Veterans General Hospital \/ Fresenius Kabi AG","highestDevelopmentStatusID":"1","companyTruncated":"Taichung Veterans General Hospital \/ Fresenius Kabi AG"},{"orgOrder":0,"company":"Kaohsiung Medical University Chung-Ho Memorial Hospital","sponsor":"TAIWAN KITOKU CO., LTD.","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"TAIWAN","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Low Protein Rice Matsubumai","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Kaohsiung Medical University Chung-Ho Memorial Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kaohsiung Medical University Chung-Ho Memorial Hospital \/ TAIWAN KITOKU CO., LTD.","highestDevelopmentStatusID":"1","companyTruncated":"Kaohsiung Medical University Chung-Ho Memorial Hospital \/ TAIWAN KITOKU CO., LTD."},{"orgOrder":0,"company":"NIN Institute","sponsor":"Centro Medico Issemym","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"INDIA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutritional Supplement","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"NIN Institute","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NIN Institute \/ Centro Medico Issemym","highestDevelopmentStatusID":"1","companyTruncated":"NIN Institute \/ Centro Medico Issemym"},{"orgOrder":0,"company":"NIN Institute","sponsor":"Hospital Civil de Guadalajara","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"INDIA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutritious Shake","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"NIN Institute","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Powder","sponsorNew":"NIN Institute \/ Hospital Civil de Guadalajara","highestDevelopmentStatusID":"1","companyTruncated":"NIN Institute \/ Hospital Civil de Guadalajara"},{"orgOrder":0,"company":"VA New York Harbor Healthcare System","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Orange Soda","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"VA New York Harbor Healthcare System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VA New York Harbor Healthcare System \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"VA New York Harbor Healthcare System \/ Undisclosed"},{"orgOrder":0,"company":"Thomas Jefferson University","sponsor":"Bausch Health","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"PEG-ELS","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Thomas Jefferson University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Liquid","sponsorNew":"Thomas Jefferson University \/ Bausch Health","highestDevelopmentStatusID":"1","companyTruncated":"Thomas Jefferson University \/ Bausch Health"},{"orgOrder":0,"company":"University of California, Irvine","sponsor":"VA Long Beach Healthcare System","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Plafond Diet","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of California, Irvine","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of California, Irvine \/ VA Long Beach Healthcare System","highestDevelopmentStatusID":"1","companyTruncated":"University of California, Irvine \/ VA Long Beach Healthcare System"},{"orgOrder":0,"company":"Ochsner Health System","sponsor":"Fresenius Medical Care | DaVita Dialysis | Food Care, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Dietary Supplement","year":"2015","type":"Inapplicable","leadProduct":"Plant Based High Protein Food Items","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Ochsner Health System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ochsner Health System \/ Fresenius Medical Care | DaVita Dialysis | Food Care, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Ochsner Health System \/ Fresenius Medical Care | DaVita Dialysis | Food Care, Inc."},{"orgOrder":0,"company":"Lingli Dong","sponsor":"Pregene","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"PRG-1801","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Lingli Dong","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lingli Dong \/ Pregene","highestDevelopmentStatusID":"1","companyTruncated":"Lingli Dong \/ Pregene"},{"orgOrder":0,"company":"PT. Daewoong Infion","sponsor":"Equilab International","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"INDONESIA","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"Recombinant Human Erythropoietin Alpha","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"PT. Daewoong Infion","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Injection","sponsorNew":"PT. Daewoong Infion \/ Equilab International","highestDevelopmentStatusID":"1","companyTruncated":"PT. Daewoong Infion \/ Equilab International"},{"orgOrder":0,"company":"Fresenius Kabi AG","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"GERMANY","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Renalive Lp Vanilla","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Fresenius Kabi AG","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fresenius Kabi AG \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Fresenius Kabi AG \/ Undisclosed"},{"orgOrder":0,"company":"Vitaflo International, Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Renastart","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Vitaflo International, Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Vitaflo International, Ltd \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Vitaflo International, Ltd \/ Undisclosed"},{"orgOrder":0,"company":"Vitaflo International, Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Renastep","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Vitaflo International, Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Liquid","sponsorNew":"Vitaflo International, Ltd \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Vitaflo International, Ltd \/ Undisclosed"},{"orgOrder":0,"company":"NYU Langone Health","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Dietary Supplement","year":"2017","type":"Inapplicable","leadProduct":"Standard Diet","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"NYU Langone Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NYU Langone Health \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"NYU Langone Health \/ Undisclosed"},{"orgOrder":0,"company":"Wayne State University","sponsor":"DaVita Dialysis | Great Lakes Dialysis, LLC | National University of Malaysia | Universiti Putra Malaysia | Ministry of Health, Malaysia | National Kidney Foundation | PEMANDU | Henry Ford Hospital | Kidney Foundation Hospital and Research Institute, Bang","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"Tocotrienol-Rich-Fraction","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Wayne State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Wayne State University \/ DaVita Dialysis | Great Lakes Dialysis, LLC | National University of Malaysia | Universiti Putra Malaysia | Ministry of Health, Malaysia | National Kidney Foundation | PEMANDU | Henry Ford Hospital | Kidney Foundation Hospital and Research Institute, Bang","highestDevelopmentStatusID":"1","companyTruncated":"Wayne State University \/ DaVita Dialysis | Great Lakes Dialysis, LLC | National University of Malaysia | Universiti Putra Malaysia | Ministry of Health, Malaysia | National Kidney Foundation | PEMANDU | Henry Ford Hospital | Kidney Foundation Hospital and Research Institute, Bang"},{"orgOrder":0,"company":"Renmin Hospital of Wuhan University","sponsor":"Wuhan Hamilton Biotechnology Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"CHINA","productType":"Cell & Gene Therapy","year":"2020","type":"Inapplicable","leadProduct":"Umbilical Cord Mesenchymal Stem Cell","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Renmin Hospital of Wuhan University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Renmin Hospital of Wuhan University \/ Wuhan Hamilton Biotechnology Co., Ltd","highestDevelopmentStatusID":"1","companyTruncated":"Renmin Hospital of Wuhan University \/ Wuhan Hamilton Biotechnology Co., Ltd"},{"orgOrder":0,"company":"University of Leicester","sponsor":"Loughborough University | YAKULT HONSHA CO LTD | Chinese University of Hong Kong | Universitaire Ziekenhuizen KU Leuven | Yakult Honsha European Research Center, ESV","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"UNITED KINGDOM","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Yakult","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Leicester","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Leicester \/ Loughborough University | YAKULT HONSHA CO LTD | Chinese University of Hong Kong | Universitaire Ziekenhuizen KU Leuven | Yakult Honsha European Research Center, ESV","highestDevelopmentStatusID":"1","companyTruncated":"University of Leicester \/ Loughborough University | YAKULT HONSHA CO LTD | Chinese University of Hong Kong | Universitaire Ziekenhuizen KU Leuven | Yakult Honsha European Research Center, ESV"},{"orgOrder":0,"company":"Palladio Biosciences","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Lixivaptan","moa":"Vasopressin V2 receptor","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Palladio Biosciences","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Palladio Biosciences \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Palladio Biosciences \/ Undisclosed"},{"orgOrder":0,"company":"Caleb Nelson","sponsor":"Otsuka Holdings","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Tolvaptan","moa":"Vasopressin V2 receptor","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Caleb Nelson","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Caleb Nelson \/ Otsuka Holdings","highestDevelopmentStatusID":"1","companyTruncated":"Caleb Nelson \/ Otsuka Holdings"},{"orgOrder":0,"company":"Creighton University","sponsor":"Dialysis Clinic","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2011","type":"Inapplicable","leadProduct":"Vitamin D3","moa":"Vitamin D receptor","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Creighton University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Creighton University \/ Dialysis Clinic","highestDevelopmentStatusID":"1","companyTruncated":"Creighton University \/ Dialysis Clinic"},{"orgOrder":0,"company":"University of British Columbia","sponsor":"Kidney Foundation of Canada | Pfizer Inc","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2010","type":"Inapplicable","leadProduct":"Vitamin D","moa":"Vitamin D receptor","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of British Columbia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of British Columbia \/ Kidney Foundation of Canada | Pfizer Inc","highestDevelopmentStatusID":"1","companyTruncated":"University of British Columbia \/ Kidney Foundation of Canada | Pfizer Inc"},{"orgOrder":0,"company":"University of Utah","sponsor":"Takeda Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Febuxostat","moa":"Xanthine dehydrogenase","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Utah","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Utah \/ Takeda Pharmaceutical","highestDevelopmentStatusID":"1","companyTruncated":"University of Utah \/ Takeda Pharmaceutical"},{"orgOrder":0,"company":"BenevolentAI","sponsor":"AstraZeneca","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2021","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"BenevolentAI","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BenevolentAI \/ AstraZeneca","highestDevelopmentStatusID":"1","companyTruncated":"BenevolentAI \/ AstraZeneca"},{"orgOrder":0,"company":"QliniQ","sponsor":"Hyloris Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"NETHERLANDS","productType":"Undisclosed","year":"2023","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"QliniQ","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"QliniQ \/ Hyloris Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"QliniQ \/ Hyloris Pharmaceuticals"},{"orgOrder":0,"company":"Dialysis Clinic","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2016","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Dialysis Clinic","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dialysis Clinic \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Dialysis Clinic \/ Undisclosed"},{"orgOrder":0,"company":"Arch Biopartners","sponsor":"Canadian Institutes of Health Research","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"CANADA","productType":"Undisclosed","year":"2023","type":"Funding","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Arch Biopartners","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Arch Biopartners \/ Canadian Institutes of Health Research","highestDevelopmentStatusID":"1","companyTruncated":"Arch Biopartners \/ Canadian Institutes of Health Research"},{"orgOrder":0,"company":"Walden Biosciences","sponsor":"University of Michigan","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"Walden Biosciences","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Walden Biosciences \/ University of Michigan","highestDevelopmentStatusID":"1","companyTruncated":"Walden Biosciences \/ University of Michigan"},{"orgOrder":0,"company":"University of Queensland","sponsor":"National Health and Medical Research Council, Australia | Applied Health Research Centre | Cambridge University Hospitals NHS Foundation Trust | University of Otago","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"AUSTRALIA","productType":"Undisclosed","year":"2018","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Queensland","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Serum","sponsorNew":"University of Queensland \/ National Health and Medical Research Council, Australia | Applied Health Research Centre | Cambridge University Hospitals NHS Foundation Trust | University of Otago","highestDevelopmentStatusID":"1","companyTruncated":"University of Queensland \/ National Health and Medical Research Council, Australia | Applied Health Research Centre | Cambridge University Hospitals NHS Foundation Trust | University of Otago"},{"orgOrder":0,"company":"MD Anderson Cancer Center","sponsor":"GE Healthcare","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Radiolabeled Compound","year":"2025","type":"Inapplicable","leadProduct":"Lu-177 PSMA","moa":"PSMA","graph1":"Nephrology","graph2":"Undisclosed","graph3":"MD Anderson Cancer Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"MD Anderson Cancer Center \/ GE Healthcare","highestDevelopmentStatusID":"1","companyTruncated":"MD Anderson Cancer Center \/ GE Healthcare"}]
Find Clinical Drug Development Pipelines & Deals | PipelineProspector
Details :
Lu-177 PSMA is a Radiolabeled Compound drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Renal Insufficiency.
Details :
Boscogen is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Kidney Failure, Chronic.
Details :
Renalive Lp Vanilla is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Renal Insufficiency, Chronic.
Details :
Nutritional Supplement is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Renal Insufficiency, Chronic.
Details :
Nutritious Shake is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Renal Insufficiency, Chronic.
Details :
Low Protein Rice Matsubumai is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Renal Insufficiency, Chronic.
Details :
The new grant will help further understand the novel mechanism of action for DPEP-1 in kidney inflammation and its impact on CKD. Arch Biopartners is developing a pipeline of new candidates that inhibit inflammation in the lungs, liver, and kidneys via D...
Details :
Global rights of the ongoing development have been licensed-in from Dutch company, QliniQ, who maintains the rights to commercialize the product candidate in its home country, and a selected number of Middle Eastern and developing countries.
Reset All
